Silver Book Fact

5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.

Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure. The American Journal of Medicine Web site. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14715324&dopt=Abstract. Published 2004

Reference

Title
Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure
Publication
The American Journal of Medicine
Publisher
Elsevier
Publication Date
Published 2004
Authors
Cowper P, DeLong E, Whellan D, LaPointe N, et al.
Volume & Issue
Volume 116, Issue 2
Pages
104-111
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, 146 new medicines are being developed for heart disease and stroke. They include 17 for stroke, 16 for congestive heart failure,…  
  • Between 1984 and 1998, the cost of treating heart attack patients rose $10,000. However, medical technology increased the life expectancy of heart attack patients by an average of 1 year-a…  
  • 277 medicines are currently in development to treat or prevent heart disease and stroke.  
  • Using technologies as treatment for heart disease helps generate cost savings, including a total of $1930 annual savings per person, and a $1.5 billion increased tax revenue  
  • “Increasing life expectancy in western society is a result of two major success stories in the prevention and treatment of human disease. The first milestone was eliminating the scourge of…